Growth, Earnings and The Future Ahead - Research Report on Accenture Plc, Towers Watson & Co., Genpact Ltd., Xerox Corp. and Corelogic Inc.

NEW YORK, February 25, 2013 /PRNewswire/ --

Today, Investors Alliance announced new research reports highlighting Accenture Plc (NYSE:ACN), Towers Watson & Co. (NYSE:TW), Genpact Ltd. (NYSE:G), Xerox Corp. (NYSE:XRX) and Corelogic Inc (NYSE:CLGX). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Accenture Plc Research Report

Accenture has been awarded a five-year, $24.4 million contract from the US National Science Foundation to help modernize the agency's financial system, upgrading its 25-year-old financial accounting system to a fully integrated, commercial-off-the-shelf software-based system hosted in a shared service environment. The company will be moving the NSF's operations towards a cloud-based financial system, in an effort to increase efficiency and effectiveness as well as optimize processes across all departments. Earlier, Accenture was awarded a two-year contract with Madrid Health Authority, to deliver consulting services targeted at enhancing the agency's existing healthcare IT systems. Meanwhile, The Street reiterates its "buy" rating with a score of A-, citing strengths in revenue, debt, stock price, earnings per share, and net income. The Full Research Report on Accenture Plc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investors-alliance.com/r/full_research_report/bf2c_ACN]

--

Towers Watson & Co. Research Report

Towers Watson saw its shares rise earlier this month after its fiscal second-quarter financial performance exceeded Wall Street's expectations Net income came in at $82.3 million or $1.15 per share, up from $67 million or 92 cents per share year over year, while revenue was up 8 percent at $946.2 million. In comparison, analysts expected earnings of $1.26 per share and revenue of $896.9 million. In addition, the company generated $278.2 million cash with income of $274.6 million over the past 12 months. For the current quarter, Towers Watson expects to earn $1.46 to $1.51 per share on revenue of $940 million to $960 million. Analysts meanwhile forecast earnings of $1.46 per share on revenue of $941.9 million. The Full Research Report on Towers Watson & Co. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investors-alliance.com/r/full_research_report/9970_TW]

--

Genpact Ltd. Research Report

Genpact released its financial results for the fourth quarter and full year ended December 31, 2012 earlier this month, with Q4 revenue of $507.7 million, 14.7% higher year over year at $442.7 million, while Q4 net income was $53.4 million, down from $61.1 million year over year. The full year 2012, revenue was up 18.8 percent at $1.9 billion from $1.6 billion year over year while net income for the year was $178.2 million, compared to $184.3 million in 2011. The increase in revenues was brought in by its expansion efforts across enterprise services offerings, industry vertical markets and geographies with both investment initiatives and acquisitions. Genpact also paid out a special cash dividend of $502 million. The Full Research Report on Genpact Ltd. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investors-alliance.com/r/full_research_report/cfd0_G]

--

Xerox Corp. Research Report

Xerox, also known for its document management and office supplies business, announced a 35 percent hike year over year in its quarterly dividend payment of 5.75 cents per share payable on April 30 this year. The company also has a share repurchase program in place, where Xerox repurchased shares worth $1.05 billion in 2012, which is expected to be duplicated this year. These come after the company posted better than expected financial results for Q4 2012, with a 38.6 percent year over year increase in net operating cash flow at $1.77 billion. The Street upgraded the company from "hold" to "buy," citing strengths in valuation levels, cash flow from operations, profit margins, debt and stock price. The Full Research Xerox Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investors-alliance.com/r/full_research_report/264f_XRX]

--

Corelogic Inc Research Report

CoreLogic beat Wall Street expectations with its Q4 financial results due to the resurgent housing market, with revenue rising 28.47 percent to $410.4 million year over year and a 125 percent year over year increase in earnings per share of 36 cents from 16 cents. Analysts meanwhile expected the company to earn $0.34 per share on revenues of $389.01 million for the quarter. CoreLogic expects to continue reinvesting in strategic growth areas and technology transformation initiatives in 2013, and even despite market forecasts indicating a reduction in loan origination volumes, management is optimistic that the company is positioned to deliver revenue and profit growth this year. The Full Research Report on Corelogic Inc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investors-alliance.com/r/full_research_report/bda7_CLGX]

--

Consider Investors Alliance

Tired of hearing about the latest, greatest trade opportunity... only to realize that the ship has long sailed? You need a strong, informative community in your arsenal. Join the group that has been consistently identifying momentous situations as they develop - long before they become the next top news on major financial networks.

Contact: Patricia Byers
Email: press@investors-alliance.com
Main: +1-480-745-7826

SOURCE Investors-Alliance

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.